BCTX
Briacell Therapeutics
BCTX
BCTX
16 hedge funds and large institutions have $33.5M invested in Briacell Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
11% less funds holding
Funds holding: 18 → 16 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
16
Holding in Top 10
2
Calls
$14.4M
Puts
$1.98M
Top Buyers
| 1 | +$13.7M | |
| 2 | +$5.07M | |
| 3 | +$2.48M | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$1.29M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$304K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$354K | |
| 3 | -$207K | |
| 4 |
IA
Insight Advisors
Newtown,
Pennsylvania
|
-$140K |
| 5 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$134K |